Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide plus R-CHOP in elderly high-risk DLBCL
NCT02753647Phase 2Unknown
- Sponsor
- Ruijin Hospital
- Start
- Apr 2016
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02753647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753647.